CSS Protein Analysis.pdf

PDF 992 KB Posted Aug 18, 2023

Attached to: Imager Protein Analysis
Solicitation number: 75N95023Q00482
Issued by: Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse

About this file

Written by GovTribe AI · Dec 21, 2023

This document is a combined synopsis and solicitation for an Imager Protein Analysis system. The National Institute on Drug Abuse (NIDA) requires a new imaging system to examine proteins through techniques such as western blotting. The solicitation seeks a LI-COR Odyssey DLx - Data Integrity Bundle Plus and Standard Extended Warranty. Responses are due by August 25, 2023. The award will be a fixed-price purchase order for one base year plus one optional year of extended warranty. Evaluation criteria include technical capability, contract management and support, and past performance. The solicitation includes standard FAR clauses and is open to all businesses meeting the applicable small business size standard of 1,000 employees or less.

View the file

On GovTribe

Work with this file

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

COMPETITIVE

COMBINED SYNOPSIS / SOLICITATION

Title: Imager Protein Analysis

RFQ: 75N95023Q00482

(i) This is a combined synopsis/solicitation for a commercial product prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

(ii) The solicitation number is 75N95023Q00482 and the solicitation is issued as a Request for Quotation (RFQ).

This acquisition is for a commercial item or service and is conducted under the authority of the FAR Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Products and Commercial Services, and is not expected to exceed the Simplified Acquisition Threshold (SAT). A fixed-price type of purchase order is contemplated for this requirement.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2023-05, dated August 8, 2023.

(iv) The North American Industry Classification System (NAICS) code for this procurement is 334516 – Analytical Laboratory Equipment and Supplies, and the small business size standard is 1,000 employees or less. This requirement shall be solicited using full and open competitive procedures.

(v) DESCRIPTION

The government requires the following brand name or equal product – (1) 9142-02 Odyssey DLx - Data Integrity Bundle Plus, (2) 9142-82E Odyssey DLx Standard Extended Warranty. This requirement shall include Options to Extend the period of performance with an additional option for extended warranty.

This product shall contain the following brand name or Salient characteristics:

• Must perform membrane quantitative westen blots

• Must perform membrane protein arrays

• Must perform gel EMSA/Gel shift assay

• Must perform gel glycoprotein staining

• Must perform gel nuclei acid gel imaging

• Must perform colorimetric and gluorescent get staining

• Must perform multi-well plate In-Cell western assay

• Must perform multi-well plate On-Cell western assay

• Must perform multi-well plate RNAi Analysis

• Must perform slide tissue section imaging

• Must perform slide protein arrays

• Must provide installation and training

• Must provide acquisition and data analysis software The system with the following brand name or equal Technical Characteristics:

• Laser Lifetime: 40,000 hours typical.

• 700 Channel Laser Source: Solid-state diode laser at 685 nm. 800 Channel Laser Source: Solid-state diode laser at 785 nm. Detectors: Silicon avalanche photodiodes.

• Scanning Speed: 5-40 cm/s.

• Resolution: 21-337 µm.

• Focus: Adjustable to be aligned to the top surface of the scan bed up to 4 mm above the scan bed to obtain the best signal-to-noise ratio of sample in membranes, gels, or microplates.

• Dynamic Range: 4 logs (Manual); >6 logs (Auto).

• Operating Conditions: For indoor use only; operating temperature 15 - 35 °C and dew point not greater than 22 °C, non-condensing; altitude not to exceed 2000 m.

• Environmental Conditions: Pollution Degree 2.

• Power Requirements: Universal input range is between 100-240 VAC (voltage fluctuations not to exceed 10% of the nominal voltage); 4 Amp maximum; at 120V, 0.5 Amp typical when idle; 50/60 Hz.

• Dimensions: 37 H × 53 W × 62 D cm (15 H × 21 W × 24.5 D inches). With the hood fully open, the Odyssey DLx requires 74 cm (29”) of vertical clearance.

• Weight: 33 kg (72 lbs).

• Network Protocol: TCP/IP.

• Network Connection: Cat. 5e RJ45, 10BASE-T/100BASE-TX/1000BASE-T. Use only the supplied cable.

Quantity:

(1) 9142-02 Odyssey DLx - Data Integrity Bundle Plus 1x

(2) 9142-82E Odyssey DLx Standard Extended Warranty 1x This product shall include shipping.

(vi) Please refer to Attachment 1 – Statement of Work for details and information The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the contractor shall warrant that the Equipment will be free from material defects for a period of twelve (12) months from the date of delivery. All service performed on this equipment shall be provided by certified and factory trained technicians. Technicians shall have the ability to diagnose the systems on site via remote access. Contractor shall provide any required replacement components due to malfunctions on-site. All travel and labor necessary to repair the instrument and all parts are provided by the vendor at no cost to the customer.

The delivery location and place of performance shall be 251 Bayview Blvd, Suite 200, BRC 06A505, Baltimore, Maryland, 21224. The POC for this delivery is Janette Lebron (lebronj@mail.nih.gov)

(viii) The provision at FAR Clause 52.212-1 Instructions to Offerors—Commercial Products and Commercial Services (MAR 2023) is applicable and incorporated by reference into this solicitation.

(ix) The provision at FAR Clause 52.212-2, Evaluation-Commercial Products and Commercial Services (NOV 2021) is applicable and incorporated by reference into this solicitation. The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered.

Each quote will be evaluated in strict conformity with the evaluation factors. The evaluation will be based upon the demonstrated capabilities of the prospective Contractor in relation to the needs of the project as set forth in the solicitation.

The quote will also be evaluated taking into consideration any price reductions for the requirement being ordered. A price reasonableness determination will be made and a best value analysis will be performed. The best value analysis will take into consideration the results of the technical evaluation, price evaluation, and the ability to complete the work within the Government's required schedule. The analysis will document that the award represents the best value to the Government (considering technical evaluation factors, past performance, and price) to meet the Government’s needs. The Government reserves the right to issue an order to the best advantage of the Government, technical merit, price, and other factors considered.

All aspects of a quote are subject to discussion, including price, technical approach and terms and conditions. At the completion of discussions, the Contractor will ensure the technical and price quote reflects the mutual understandings of the requirement and if requested, submit a revised technical and price quote to the Contracting Officer.

The Government may request clarifying information from the Contractor, as it relates to its quote.

If an award will be made without conducting discussions, Contractors may be given the opportunity to clarify certain aspects of their quote (e.g., the relevance of the contract, the Contractor's past performance information, and adverse past performance information to which the Contractor has not previously had an opportunity to respond) or to resolve minor or clerical errors. Discussions will not be held with any Offeror determined to be technically unacceptable.

The Government reserves the right to make a single award, multiple awards, or no award at all as a result of the solicitation. In addition, the solicitation may be amended or canceled as necessary to meet the Government’s requirements.

A tradeoff process shall be used for this acquisition because it has been determined to be in the best interest of the Government to consider award to other than the lowest priced Offeror or other than the highest technically rated offeror. All evaluation factors other than cost or price, when combined, are more important than cost or price. For this acquisition, the following considerations will be part of the trade-off process: Technical Evaluation Factors including Past Performance, and Price.

The evaluation factors are used by the technical evaluation committee when reviewing the technical quotes. The factors below are listed in order of its relative importance for evaluation purposes.

1. Technical Capability and Functionality

NIDA shall evaluate the offeror’s technical approach for overall capability and functionality in relation to the General Requirement, Salient Characteristics, Quantity and Deliverables as described in the Purchase Description.

2. Contract Management and Customer Support

NIDA shall evaluate the offeror’s ability to provide a high level of customer service, particularly in the area of initial responsiveness and resolution of device and service problems. Specifically, the Government will evaluate the Offeror’s capability based on its description of any applicable warranty and customer support process.

3. Speed of Delivery, Installation and Set-up

NIDA shall evaluate the offeror’s technical approach for completeness, feasibility, soundness and practicality of the proposed approach and work plan for accomplishing the requirements of the Purchase Description.

PAST PERFORMANCE

The Offeror should provide past performance information. Past performance information should cover a minimum of one (1) year in relevant services and deliveries of comparable systems. The Offeror should provide at least one reference for any project identified under the experience factor that has a performance period within the past three (3) years. For each reference, the offeror should provide the following: (1) Organization or contracting partner's name; (2) Point of contact's (POCs) name and contact information (i.e., current phone numbers and valid email addresses); and (3) a description that precisely explains the general scope and specific requirements of the contract.

Offerors will be evaluated based on information obtained from references provided by the offeror, other relevant past performance information obtained from other sources known to the Government, and any information supplied by the offeror concerning problems encountered on the identified contracts and corrective action taken.

Furthermore, the Government will assess the relative risks associated with each offeror.

Performance risks are those associated with an offeror's likelihood of success in performing the acquisition requirements as indicated by that offeror's record of past performance. The assessment of performance risk is not intended to be the product of a mechanical or mathematical analysis of an offeror's performance on a list of contracts but rather the product of subjective judgment by the Government after it considers all available and relevant information.

PRICE EVALUATION

Offerors price quote will be evaluated for reasonableness. For a price to be reasonable, it must represent a price to the government that a prudent person would pay when consideration is given to prices in the market. Normally, price reasonableness is established through adequate price competition, but may also be determined through cost and price analysis techniques. Price evaluation will not be conducted on any Offeror determined to be technically unacceptable.

EVALUATION OF OPTIONS

The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. Evaluation of options will not obligate the Government to exercise the option(s)

(x) The provision at FAR Clause 52.212-3, Offeror Representations and Certifications - Commercial Products and Commercial Services (DEC 2022), is applicable and incorporated by reference into this solicitation.

(xi) The provision at FAR Clause 52.212-4, Contract Terms and Conditions—Commercial Products and Commercial Services (DEC 2022), applies to this acquisition. See Attachment 2.

(xii) The provision of FAR Clause 52.212-5, Contract Terms and Conditions Required to

Implement Statutes or Executive Orders - Commercial Products and Commercial Services (JUN 2023), applies to this acquisition. See Attachment 3.

(xiii) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition.

(xiv) The Defense Priorities and Allocations System (DPAS) is not applicable to this requirement.

(xv) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. Responses to this solicitation must include clear and convincing evidence of the Offeror’s capability of fulfilling the requirement as it relates to the government requirements stated in this solicitation.

Basic cost and price information in the Offeror’s proposal must contain sufficient information to allow the Government to perform a basic analysis of the reasonableness of the Offeror to supply the required goods/services. Any other information or factors that may be considered in the award decision may include such factors as: past performance; special features required for effective service coverage; trade-in considerations; warranty considerations; maintenance and service coverage availability;

serial, product or catalog number(s); product description; delivery terms, and prompt payment discount terms.

The Contractor shall submit its quote electronically.

Offerors MUST verify the valid certifications, registrations, and Representation and Certifications from the System of Award Management (SAM) applications at www.SAM.gov, which may be indicated on the Offeror’s cover sheet.

In addition the vendor Unique Entity Identifier (UEI) and the certification of business size must be included in the response. All Offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All responses must be received no later than August 25, 2023, 11:00 AM EST. Late responses may not be accepted. All responses must reference solicitation number 75N95023Q00482. Responses must be submitted electronically to the Contract Specialist, Andrew Varley, at Andrew.Varley@nih.gov. with a copy also to the Contracting Officer, Josh Lazarus, at josh.lazarus@nih.gov. For information regarding this solicitation, please contact Andrew Varley by email at Andrew.Varley@nih.gov. or by phone at 301-827-5851.

(xvi) DATE QUESTIONS DUE: Questions and requests for clarification must be submitted electronically to the Contract Specialist, Andrew Varley, at Andrew.Varley@nih.gov. on or before 11:00 AM EST, August 22, 2023. Fax responses will NOT be accepted.

ATTACHMENTS

- Attachment 1 – Purchase Description (PD)

- Attachment 2 - FAR 52.212-4, Contract Terms and Conditions - Commercial Products and Commercial Services (DEC 2022)

- Attachment 3 - FAR 52.212-5, Contract Terms and Conditions Required to Implement

Statutes or Executive Orders - Commercial Products and Commercial Services (JUN 2023)

- Attachment 4 – Invoice and Payment Instructions

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

CSS No. 75N95023Q00482 Attachment #1- Purchase Description

PURCHASE DESCRIPTION

1. Statement of Need and Purpose:

The NIDA IRP Cellular Stress and Inflammation (CSI) is looking to procure a new imaging system to examine protein through western blotting and other assays. CSI was established for the purpose of studying the role of endoplasmic reticulum (ER) stress and inflammation in neuronal dysfunction caused by substance abuse or neurodegenerative diseases. Protein analysis is an essential technique for the CSI examine and quantify target proteins. The current imaging Li-Cor system was acquired over a decade ago and needs to be replaced with a more functional imaging system.

The replacement system will be shared with the Hope laboratory and Genetic Engineering and Viral Vector Core.

2. Background Information and Objective: The NIDA IRP Mission is to conduct state-of-the-art basic, preclinical and clinical research on mechanisms that underlie substance use disorders, addiction and relapse. Ultimately we hope to translate these efforts into new methods for the prevention and treatment of substance use disorders highlighting the following: enhancing our research by taking advantage of our unique and outstanding strengths; increasing translational research and fortifying our clinical portfolio; strengthening our basic science with investment in technology; increasing Diversity and Inclusion at all levels; and prioritizing Trans-NIH initiatives and growing strong ties with other institutes. CSI currently has a Li-Cor imaging system near the end of its functional usage that was acquired over a decade ago and needs to replaced soon.

NIDA requires an Imager for protein analysis to examine and quantify blots and can perform more optimized analytical applications for current and future experiments involving protein expression/level..

CSI was established for the purpose of studying the role of endoplasmic reticulum stress and inflammation in neuronal dysfunction caused by substance abuse or neurodegenerative diseases. In addition, identifying the biology of secreted ER calcium modulated proteins (SERCaMPs) and KDEL receptors.

3. Name of Product: Imager for protein analysis

4. Purchase Description:

The government requires the following brand name or equal product – (1) 9142-02 Odyssey DLx - Data Integrity Bundle Plus, (2) 9142-82E Odyssey DLx Standard Extended Warranty.

This product shall contain the following brand name or Salient characteristics:

• Must perform membrane quantitative westen blots

• Must perform membrane protein arrays

• Must perform gel EMSA/Gel shift assay

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

Attachment #1- Purchase Description

• Must perform gel glycoprotein staining

• Must perform gel nuclei acid gel imaging

• Must perform colorimetric and gluorescent get staining

• Must perform multi-well plate In-Cell western assay

• Must perform multi-well plate On-Cell western assay

• Must perform multi-well plate RNAi Analysis

• Must perform slide tissue section imaging

• Must perform slide protein arrays

• Must provide installation and training

• Must provide acquisition and data analysis software The system with the following brand name or equal Technical Characteristics:

• Laser Lifetime: 40,000 hours typical.

• 700 Channel Laser Source: Solid-state diode laser at 685 nm. 800 Channel Laser Source:

Solid-state diode laser at 785 nm. Detectors: Silicon avalanche photodiodes.

• Scanning Speed: 5-40 cm/s.

• Resolution: 21-337 µm.

• Focus: Adjustable to be aligned to the top surface of the scan bed up to 4 mm above the scan bed to obtain the best signal-to-noise ratio of sample in membranes, gels, or microplates.

• Dynamic Range: 4 logs (Manual); >6 logs (Auto).

• Operating Conditions: For indoor use only; operating temperature 15 - 35 °C and dew point not greater than 22 °C, non-condensing; altitude not to exceed 2000 m.

• Environmental Conditions: Pollution Degree 2.

• Power Requirements: Universal input range is between 100-240 VAC (voltage fluctuations not to exceed 10% of the nominal voltage); 4 Amp maximum; at 120V, 0.5 Amp typical when idle; 50/60 Hz.

• Dimensions: 37 H × 53 W × 62 D cm (15 H × 21 W × 24.5 D inches). With the hood fully open, the Odyssey DLx requires 74 cm (29”) of vertical clearance.

• Weight: 33 kg (72 lbs).

• Network Protocol: TCP/IP.

• Network Connection: Cat. 5e RJ45, 10BASE-T/100BASE-TX/1000BASE-T. Use only the supplied cable.

5. Quantity:

(1) 9142-02 Odyssey DLx - Data Integrity Bundle Plus 1x

(2) 9142-82E Odyssey DLx Standard Extended Warranty 1x

6. Delivery Date:

Desired delivery date is 30 days of receipt of order.

7. Period of Performance:

One year plus one extra year of standard extended warranty (optional)

8. Option(s): One extra year of standard extended warranty

Addendum to FAR 52.212-4 Terms and Conditions – Commercial Items

(s) Order of precedence. Any inconsistencies in this solicitation or contract shall be resolved by giving precedence in the following order:

(1) The schedule of supplies/services

(2) The Assignments, Disputes, Payments, Invoice, Other Compliances, Compliance with Laws Unique to Government Contracts, Unauthorized Obligations, and Commercial Supplier Agreements – Unenforceable Clauses paragraphs of this clause.

(3) The clause at 52.212-5.

(4) Addenda to this solicitation or contract, including any commercial supplier agreements as amended by the Commercial Supplier Agreements – Unenforceable Clauses provision.

(5) Solicitation provisions if this is a solicitation.

(6) Other paragraphs of this clause.

(7) The Standard Form 1449.

(8) Other documents, exhibits, and attachments.

(9) The specification.

(w) Commercial supplier agreements–unenforceable clauses.

(1) Definition. For the purpose of this contract, “Commercial supplier agreements” (referred to at FAR 12.216 as “Supplier License Agreements”) means terms and conditions customarily offered to the public by vendors of supplies or services that meet the definition of “commercial item” set forth in FAR 2.101 and intended to create a binding legal obligation on the end user. Commercial supplier agreements are particularly common in information technology acquisitions, including acquisitions of commercial computer software and commercial technical data, but they may apply to any supply or service. The term applies–

(a) Regardless of the format or style of the document. For example, a commercial supplier agreement may be styled as standard terms of sale or lease, Terms of Service (TOS), End User License Agreement (EULA), or another similar legal instrument or agreement, and may be presented as part of a proposal or quotation responding to a solicitation for a contract or order;

(b) Regardless of the media or delivery mechanism used. For example, a commercial supplier agreement may be presented as one or more paper documents or may appear on a computer or other electronic device screen during a purchase, software installation, other product delivery, registration for a service, or another transaction.

Attachment #2- FAR 52.212-4 Terms and Conditions

(2) When any supply or service acquired under this contract is subject to a commercial supplier agreement, and notwithstanding any other provision of this agreement, when the end user is an agency or instrumentality of the U.S. Government, the following language shall be deemed incorporated into the commercial supplier agreement. As used herein, “this agreement” means the commercial supplier agreement.

(i) Applicability. This agreement is a part of a contract between the commercial supplier and the U.S. Government for the acquisition of the supply or service that necessitates a license or other similar legal instrument (including all contracts, task orders, and delivery orders under FAR Part 12).

(ii) End user. This agreement shall bind the ordering activity as end user but shall not operate to bind a Government employee or person acting on behalf of the Government in his or her personal capacity.

(iii) Law and disputes. This agreement is governed by Federal law.

(A) Any language purporting to subject the U.S. Government to the laws of a U.S. state, U.S. territory, district, or municipality, or a foreign nation, except where Federal law expressly provides for the application of such laws, is hereby deleted.

(B) Any language requiring dispute resolution in a specific forum or venue that is different from that prescribed by applicable Federal law is hereby deleted.

(C) Any language prescribing a different time period for bringing an action than that prescribed by applicable Federal law in relation to a dispute is hereby deleted.

(iv) Continued performance. The supplier or licensor shall not unilaterally revoke, terminate or suspend any rights granted to the Government except as allowed by this contract. If the supplier or licensor believes the ordering activity to be in breach of the agreement, it shall pursue its rights under the Contract Disputes Act or other applicable Federal statute while continuing performance as set forth in subparagraph 52.212-4(d) (Disputes).

(v) Arbitration; equitable or injunctive relief. In the event of a claim or dispute arising under or relating to this agreement, a binding arbitration shall not be used unless specifically authorized by agency guidance, and equitable or injunctive relief, including the award of attorney fees, costs or interest, may be awarded against the U.S. Government only when explicitly provided by statute (e.g., Prompt Payment Act or Equal Access to Justice Act).

(vi) Updating terms.

(A) After award, the contractor may unilaterally revise commercial supplier agreement terms if they are not material. A material change is defined as:

(1) Terms that change Government rights or obligations;

(2) Terms that increase Government prices;

(3) Terms that decrease overall level of service; or

(4) Terms that limit any other Government right addressed elsewhere in this contract.

(B) For revisions that will materially change the terms of the contract, the revised commercial supplier agreement must be incorporated into the contract using a bilateral modification.

(C) Any agreement terms or conditions unilaterally revised subsequent to award that are inconsistent with any material term or provision of this contract shall not be enforceable against the Government, and the Government shall not be deemed to have consented to them.

(vii) No automatic renewals. If any license or service tied to periodic payment is provided under this agreement (e.g., annual software maintenance or annual lease term), such license or service shall not renew automatically upon expiration of its current term without prior express consent by an authorized Government representative.

(viii) Indemnification. Any clause of this agreement requiring the commercial supplier or licensor to defend or indemnify the end user is hereby amended to provide that the U.S.

Department of Justice has the sole right to represent the United States in any such action, in accordance with 28 U.S.C. 516.

(ix) Audits. Any clause of this agreement permitting the commercial supplier or licensor to audit the end user’s compliance with this agreement is hereby amended as follows:

(A) Discrepancies found in an audit may result in a charge by the commercial supplier or licensor to the ordering activity. Any resulting invoice must comply with the proper invoicing requirements specified in the underlying Government contract or order.

(B) This charge, if disputed by the ordering activity, will be resolved in accordance with subparagraph (d) (Disputes); no payment obligation shall arise on the part of the ordering activity until the conclusion of the dispute process.

(C) Any audit requested by the contractor will be performed at the contractor's expense, without reimbursement by the Government.

(x) Taxes or surcharges. Any taxes or surcharges which the commercial supplier or licensor seeks to pass along to the Government as end user will be governed by the terms of the underlying Government contract or order and, in any event, must be submitted to the Contracting Officer for a determination of applicability prior to invoicing unless specifically agreed to otherwise in the Government contract.

(xi) Non-assignment. This agreement may not be assigned, nor may any rights or obligations thereunder be delegated, without the Government's prior approval, except as expressly permitted under subparagraph (b) of this clause.

(xii) Confidential information. If this agreement includes a confidentiality clause, such clause is hereby amended to state that neither the agreement nor the contract price list, as applicable, shall be deemed “confidential information.” Issues regarding release of “unit pricing” will be resolved consistent with the Freedom of Information Act. Notwithstanding anything in this agreement to the contrary, the Government may retain any confidential information as required by law, regulation or its internal document retention procedures for legal, regulatory or compliance purposes; provided, however, that all such retained confidential information will continue to be subject to the confidentiality obligations of this agreement.

(3) If any language, provision, or clause of this agreement conflicts or is inconsistent with the preceding paragraph (1), the language, provisions, or clause of paragraph (1) shall prevail to the extent of such inconsistency.

(End of clause)

52.217-9 Option to Extend the Term of the Contract The Government may extend the term of this contract by written notice to the Contractor within 5 calendar days of contract expiration; provided that the Government gives the Contractor a preliminary written notice of its intent to extend at least 5 calendar days before the contract expires.

The preliminary notice does not commit the Government to an extension. If the Government exercises this option, the extended contract shall be considered to include this option clause. The total duration of this contract, including the exercise of any options under this clause, shall not exceed 5 years.

��	��	��
��	��

!"#$%&'$(#)�"**('+%�',+'-�&.�&//%"/%(&$+01234�567�89:;<=>;9<�?6=@@�>9AB@C�DE;6�;67�FGH�>@=I?7?�E:�;6E?�B=<=J<=B6�234�;6=;�;67�89:;<=>;E:J�KLLE>7<�6=?�E:ME>=;7M�=?�37E:J�E:>9<B9<=;7M�E:�;6E?�>9:;<=>;�3C�<7L7<7:>7�;9�EAB@7A7:;�B<9NE?E9:?�9L�@=D�9<�OP7>I;EN7�9<M7<?�=BB@E>=3@7�;9�=>QIE?E;E9:?�9L�>9AA7<>E=@�E;7A?R S S

2T42U42V42W42X42Y42Z42[42\42T]42TT4

XÛU]V_YXÛU]V_TVXÛU]V_TXXÛU]W_T]XÛU]W_TWXÛU]W_TXXÛU]\_YXÛU]\_\XÛUT\_V

H7?;<E>;E9:?�9:�̀I3>9:;<=>;9<�̀=@7?�;9�;67�a9N7<:A7:;�2bI:7�U]U]4c�DE;6�G@;7<:=;7�d�2e9N�U]UT4�2WT�f̂`̂8̂�WZ]W�=:M�T]�f̂`̂8̂�WYXX4̂�89:;<=>;9<�89M7�9L�gI?E:7??�O;6E>?�=:M�89:MI>;�2e9N�U]UT4�2WT�f̂`̂8̂�VX]\44̂�h6E?;@73@9D7<�i<9;7>;E9:?�I:M7<�;67�GA7<E>=:�H7>9N7<C�=:M�H7E:N7?;A7:;�G>;�9L�U]]\�2bI:7�U]T]4�2̀7>;E9:�TXXV�9L�iI3̂�ĵ�TTT_X4̂�2GBB@E7?�;9�>9:;<=>;?�LI:M7M�3C�;67�GA7<E>=:�H7>9N7<C�=:M�H7E:N7?;A7:;�G>;�9L�U]]\̂4�H7B9<;E:J�OP7>I;EN7�89AB7:?=;E9:�=:M�FE<?;_5E7<�̀I3>9:;<=>;�GD=<M?�2bI:�U]U]4�2iI3̂�ĵ�T]\_U[U4�2VT�f̂`̂8̂�YT]T�:9;74̂�kH7?7<N7Ml̂7̀<NE>7�89:;<=>;�H7B9<;E:J�H7QIE<7A7:;?�2K>;�U]TY4�2iI3̂�ĵ�TTT_TTZc�?7>;E9:�ZWV�9L�mEN̂�84̂�7̀<NE>7�89:;<=>;�H7B9<;E:J�H7QIE<7A7:;?�L9<�d:M7LE:E;7_m7@EN7<C�89:;<=>;?�2K>;�U]TY4�2iI3̂�ĵ�TTT_TTZc�?7>;E9:�ZWV�9L�mEN̂�84̂�i<9;7>;E:J�;67�a9N7<:A7:;n?�d:;7<7?;�h67:�̀I3>9:;<=>;E:J�DE;6�89:;<=>;9<?�m73=<<7Mc�̀I?B7:M7Mc�9<�i<9B9?7M�L9<�m73=<A7:;̂�2e9N�U]UT4�2VT�f̂`̂8̂�YT]T�:9;74̂�fBM=;7?�9L�iI3@E>@C�GN=E@=3@7�d:L9<A=;E9:�H7J=<ME:J�H7?B9:?E3E@E;C�o=;;7<?�2K>;�U]T[4�2WT�f̂`̂8̂�UVTV4̂�kH7?7<N7Ml̂e9;E>7�9L�pfgq9:7�̀7;_G?EM7�9<�̀9@7_̀9I<>7�GD=<M�2K>;�U]UU4�2TX�f̂`̂8̂YXZ=4̂

2=4�567�89:;<=>;9<�?6=@@�>9AB@C�DE;6�;67�L9@@9DE:J�F7M7<=@�G>QIE?E;E9:�H7JI@=;E9:�2FGH4�>@=I?7?c�D6E>6�=<7�E:>9<B9<=;7M�E:�;6E?�>9:;<=>;�3C�<7L7<7:>7c�;9�EAB@7A7:;�B<9NE?E9:?�9L�@=D�9<�OP7>I;EN7�9<M7<?�=BB@E>=3@7�;9�=>QIE?E;E9:?�9L�>9AA7<>E=@�B<9MI>;?�=:M�>9AA7<>E=@�?7<NE>7?R��2T4�XÛU]V_T\c�i<96E3E;E9:�9:�H7QIE<E:J�87<;=E:�d:;7<:=@�89:LEM7:;E=@E;C�GJ<77A7:;?�9<�̀;=;7A7:;?�2b=:�U]TZ4�2?7>;E9:�ZWV�9L�mENE?E9:�Oc�5E;@7�rddc�9L�;67�89:?9@EM=;7M�=:M�FI<;67<�89:;E:IE:J�GBB<9B<E=;E9:?�G>;c�U]TX�2iI3̂�ĵ�TTV_UVX4�=:M�E;?�?I>>7??9<�B<9NE?E9:?�E:�?I3?7QI7:;�=BB<9B<E=;E9:?�=>;?�2=:M�=?�7P;7:M7M�E:�>9:;E:IE:J�<7?9@I;E9:?44̂��2U4�XÛU]W_UVc�i<96E3E;E9:�9:�89:;<=>;E:J�L9<�p=<MD=<7c�̀9L;D=<7c�=:M�̀7<NE>7?�m7N7@9B7M�9<�i<9NEM7M�3C�s=?B7<?tC�j=3�=:M�K;67<�89N7<7M�O:;E;E7?�2e9N�U]UT4�2̀7>;E9:�TYVW�9L�iI3̂�ĵ�TTX_\T4̂��2V4�XÛU]W_UXc�i<96E3E;E9:�9:�89:;<=>;E:J�L9<�87<;=E:�57@7>9AAI:E>=;E9:?�=:M�rEM79�̀I<N7E@@=:>7�̀7<NE>7?�9<�OQIEBA7:;̂�2e9N�U]UT4�2̀7>;E9:�[[\2=42T42G4�9L�iI3̂�ĵ�TTX_UVU4̂��2W4�XÛU]\_T]c�i<96E3E;E9:�9:�89:;<=>;E:J�DE;6�d:N7<;7M�m9A7?;E>�89<B9<=;E9:?�2e9N�U]TX4̂��2X4�XÛUVU_W]c�i<9NEME:J�G>>7@7<=;7M�i=CA7:;?�;9�̀A=@@�gI?E:7??�̀I3>9:;<=>;9<?�2o=<�U]UV4�2�VT�f̂`̂8̂�V\]V�=:M�T]�f̂`̂8̂�V[]T4̂��2Y4��XÛUVV_Vc�i<9;7?;�GL;7<�GD=<M�2GIJ�T\\Y4�2�VT�f̂`̂8̂�VXXV4̂��2Z4��XÛUVV_Wc�GBB@E>=3@7�j=D�L9<�g<7=>6�9L�89:;<=>;�8@=EA�2K>;�U]]W4�2iI3@E>�j=D?�T][_ZZ�=:M�T][_Z[�2�T\�f̂`̂8̂�V[]X�:9;744̂

Attachment #3- FAR 52.212-5 Clauses

��./�'��-0��1��%&��#�'� �''�%��2'�-��"�%�(��

��2�� 3��4�� %&��#�'� �''�%��2'�-��"�%�(��

��2�� 3��4�� "��5�� %&��#�'� �''�(� �� '��)��"�%�(�� -�� -�� %&��#�'� �''�%�6�� 7�� )��"�%�(�� 2�� 3��2�� 33��2�� 333��8� ��2�� 39��%�,��%��2'�-��)�-��'��4��"�%�(��

��:�&�� '�� %�6�� 7��)��"�%�(�� :�;��-��-�<�&�7�'=%�6�� 7�� %�,��"�%�(�� >��%��<�'�6��-�9�� )+ �-�%&��#�'� �''�%��2'�-��)��"�%�(�� '��2+��-�%&��#�'� �''��7��&�/��,��'� �� 4�� "�%�(�� 4�?��;�� &,�� 2�� 3��4��%��2'�-��%��%��2+��-�� &��?�<�'�-�� 7�-�@�&� �)+ �-�%&��#�'� �''�(� �� '��)��"�%�(�� &��%��2'�-��%��%��2+��-��@�&� �)+ �-�%&��#�'� �''�(� �� '��7�6��" -��*��@�&� �)+ �-�%&��#�'� �''��7��&��)��"�%�(�� &��)�-��'�3''��-�<��?�" -��%&��#�'� �''�/�'��'��4��"�%�(��

��2�� 3��4��

�	��
��	��
��	�

�

��

�

��

�

��

�

��

�

��

�

��

�

��

�

��

�

��

�

��

�	�		��
	�	�		��
��	�		��
��	�		��
��	�		��
��	�		��
�	�		��	�

	��,��!��-�.�/��/��#�0��"��(��'%��	�
��1��"� %%��2��.�%��	�

	��'"��3��0��
��-��	�	�	��3-��!�(��(��!��4�#5�(���(�!��&��#��1��"� %%��2�-��6��(��	�	��

�7�.��

	��'"��3��"2�	�
��-��	�		��3-��!�(��8��(��!��4�#5�(���(�!��&��#��1��"� %%��2�-��9��4��(�&��!�+�(��"��(��	�	��	��7�.��'"��3��"2�	�
��-��	�		��3-��!�(��8��(��!��4�#5�(���(�!��&��#��%"�2��)�%��(��6��(��	�	��

�7�.�� :��-��-��*%"�2��)�/!�(�7�#��!��:��"��)�"��(�'��+��

��*��/�;��--��4��/��,��(��(��:��	�
��		�7�.��!�%��

��	��'"��3��<��	�
��-��	�		��	�7�.��!�%��

��	��'"��3��1��(�� %"��%"�2*��"�/��"��2�6��-��<�2�	�		��8�� #��
	�
��:��%%"��"��!��1��(��-��*��""2��"��"��--��!��(!�"-��(��!��2%�(��-����"�%��#��(����"�(��(��(�%��(��#��0')�		�
��(����-�,��/��-�)��#�<��"��-��,'=+�(�/��#�3��(��<�2�	��
��	�7�.��	��'��:��%%"��"��!��1��(��-��*��""2��"��"��--��!��(!�"-��(��)�1��(�� *%"��'"��3��<�2�	��
��-��	�		��	�7�.��	��	��:��%%"��"��!��1��(��-��*��""2��"��"��--��!��(!�"-��(��'"��3��1��(��-�� >��+�%"��/�.��(��(��#�?�/!�@"��"�9��*��/�,��"�?2#��-"��(��7:�	�

��)�1��(��*%"��<��5�.��5�)�%��5��+�(%�(�"��-�)�-��/��1��%*��#�'��#��(��7:� � ��5�'�1��(��-��,�';A�)�/�(��#�3*�/��/��1��%*��7:� �

��'"��3��	�
��-��	�	��
��'�1��(��-��,�';A�)�/�(��#�;�"��(��(��7:�	�

��'"��3��	�
��-��	�		��
��/2��--��2��/2��(�*��/�,��#��(��<'B�	�	��	�7�.��
	��5�'�1��(��-��,�';A�)�/�(��#�,��(��"��*%��,��#��(�� ;�	�

��'"��3��	�
��-��	�		��
��/��/��,�"��(��C��;�8��<�((�/��/�9!�"��+��/��	�	��

��'��(�"(��7:� �

��	��	��
��	��	��	��	��	��

	��
��	��
	��	��	��	�
	��	�		��	��
	��	��	��	��		��
��	��

�	��
��	��	��

��	��&�'��		��%()�#�)�+��%��
��,�	��
��	��	��-.!�%��� #�&.//(��� )��

��&�'�� 0�/)*�� -.!�%�*�� #��**�"��1*�%$�**�*#)��+��*(��"��1*�% )��2* ��

��#�)*��&�'�� 0�/)*��* )��#�� .3(� �4�5��

��#1�� %()*�#�)*�+�67*�*��*18��%()*�#�)*�++��2* �� "��1*�%$�**�*#)��2* �� *)��*9��&�'��

��#�)*��7*�)�� )��#��#�'*�)��#��*�$#��.� 0��*��*3�� :��/�� (��)��#��#1��)�).)*��1��#��)*�*1�3!�)0*��,,� *��,��*�$#�%��*)��'�#)��(��,�)0*�2*/��)�*#)��,�)0*�"�*��.�!��'�#)�� )��*�,��#$��)*�&* .��)!��.# )��#��.)��1*�)0*��#�)*1�&)�)*�� )�� &* )��#��*#1*1��,�)0*��)��#�(�2*,*#�*�%.)0��;�)��#�% )�,�� (�<*��

��)*��)� *��,�2��)*��*�$*# !�%�*��&*)�%��1*��

��7*9.��*��'�� /(*)��#�7*�)�� )��#��#�&.3 �#)�� )�#$��.)��1*�2��)*��*�$*# !�%�*��

��"*��,��#�# �#$��,��.� 0��*��,�'��*� ��(��1. )��#1�'��*� ��(�&*�� *�� +#�)�((�*#)��!�*#)��,��'��*� ��(��1. )��#1�'��*� ��(�&*�� *�� !�*#)�3!��(* )��#� ��.#1��"��#�,*�>&!�)*��,��%5��1�?�#�$*�*#)�� )��

��!�*#)�3!��(* )��#� ��.#1��"��#�,*�>�)0*��)0�#�&!�)*��,��%5��1�?�#�$*�*#)��.(��

��7*9.��*��'�� /(*)�)��#��!�*#)�3!�"0��1��)!��?�!��

�� !��&* .��)!�&�,*$.��1��%.$��	��&�'��	��!�#)��)��&��((�-.��#��&.3 �#)�� )��%��
��	��&�'��

��1�� *,*�*# *�,��)*(!��5#*1��&��(�$�'��*� ��(�@*��*(�� #1��

��,�	��%()�#�)�++��
��,�	��

"�A��#�'*�)��#��*�$#�� .�*�*#)�>��)� *��#1�7*/�*�*#)�)��#��*3��

��	��
��	��

��	��
��	��
��	��
��	�� !��	��

��	��	��
��	��
��	��
��#$%&'()'+&,�-..+/(�0/1�)2�)33(%3(+)'/456 7848889:; </(=+/�$%&'()'�>)?%(�<')&@)(@2�ABC,�8D;EF�A:;�G4<4$4�0)3'/(�HIF4�A;F 7848889:8 <')'/J/&'�%.�KLC+=)M/&'�N)'/2�.%(�O/@/()M�P+(/2�AQ)R�8D;:F�A8S�G4<4$4�8DH�)&@�:;�G4<4$4�0)3'/(�HIF4�N/LC+(/2�$-�%J3M/'+%&4A8F6 7848889:T O)+(�>)?%(�<')&@)(@2�B'�)&@�</(=+/�$%&'()'�>)?%(�<')&@)(@29U(+/�B@VC2'J/&'�AQCM'+3M/�W/)(�)&@�-3'+%&�$%&'()'2F�ABC,�8D;EF�A8S�G4<4$4�8DH�)&@�:;�G4<4$4�0)3'/(�HIF4�ATF6 7848889:: O)+(�>)?%(�<')&@)(@2�B'�)&@�</(=+/�$%&'()'�>)?%(�<')&@)(@2XU(+/�B@VC2'J/&'�AQ)R�8D;:F�A8S�G4<4$4�8DH�)&@�:;�G4<4$4�0)3'/(�HIF4�A:F 78488897; KY/J3'+%&�.(%J�B33M+)'+%&�%.�'0/�</(=+/�$%&'()'�>)?%(�<')&@)(@2�'%�$%&'()'2�.%(�Q)+&'/&)&/Z�$)M+?()'+%&Z�%(�N/3)+(�%.�$/(')+&�KLC+3J/&'XN/LC+(/J/&'2�AQ)R�8D;:F�A:;�G4<4$4�0)3'/(�HIF4�A7F 78488897T KY/J3'+%&�.(%J�B33M+)'+%&�%.�'0/�</(=+/�$%&'()'�>)?%(�<')&@)(@2�'%�$%&'()'2�.%(�$/(')+&�</(=+/2XN/LC+(/J/&'2�AQ)R�8D;:F�A:;�G4<4$4�0)3'/(�HIF4�AHF6 784888977 Q+&+JCJ�[),/2�G&@/(�KY/C'+=/�-(@/(�;TH7E�A\)&�8D88F4�AIF6 7848889H8 U)+@�<+1�>/)=/�G&@/(�KY/C'+=/�-(@/(�;TIDH�A\B]�8D;IF�AK4-4�;TIDHF4�AEF 78488H9H U(%J%'+&,�KY/22�O%%@�̂%&)'+%&�'%�]%&3(%.+'�-(,)&+_)'+%&2�A\C&�8D8DF�A:8�G4<4$4�;IS8F4�ASF��	��	��̀�

� �� a��

��	��
��	��	��
��	��

��bacdc��

��	��
	��

��ebabcefb�� gh�� a��c�� ̀� �� i ��j� �� k��

��	�
��	��!

�� l��

��	��
�	��

��a��b�� m��

��	��
��	��!

��n��

��	��	��
��	��	��

��oap��

��	��	��
��	��

��a�q��

�� m��

�� n��

�a��

�	��
��	��

�� a��n��

��	��
��		m��	��

��	��	��a��	��
	��"��

��	��	��
��	��

��	��	��
	��

��	��	��
��	��
��	�
��	��
�	��

�a�

��%&!&'($�/��0�� 1��

��2 ��&'�3�� 3-(��4

��*��5 ��,11��

��&'�%��0��!�6!��($&(%��

��%&!&'-$&(��0��

��7 ��4� ��0�� 8 ��9��6 ��:(-��0��!�6!��%$/��!�� %&!&'-$&%��0�� 5�� 0��!�6!��%$&(&�!�� %&!&�/$;��"� ��+��&'&&��%�"!.!�!�:(3��&�� !�1�� /!3'&�

��%&!&&&$&��0�� 0��&'�%�!��

��.*0�&'�%��*!+!��&-:�!��

��2"��&'&'��(;�"!.!�!�-&�&�!�� =��9�� 4 ��2"��&'&'��&/�"!.!�!�3/(�!��#��%&!&&&$(3��*��,�� 2"��&'&'��(;�"!.!�!�-&�&�!��# ��6 ��4*��&'�'��*!+!��(-/:�!��

��6 ��:3�!��#

��5� �9 ��0��+,�&'&��&&�"!.!�!�� 3;� ��*!+��(:&3�!��)�� 1��?��&'�%��%&!&&&$%'��&&�"!.!�!�� 3;� ��*!+!��(:&3�!��# ��6 ��:3�!��# ��%&!&&&$%(��*#�� 6 ��:3�!��#

��+��(:%;��2��&'&&�!��#

��%&!&&&$:&��0 �9�6� ��+��(3':��2��&'�3��*!+!��(3':�!��# #��%&!&&-$(��0�

��5� ��2 ��&'�3��%�"!.!�!�%%& ��1��2��&'�3��%&!&&-$(!��##��%&!&&%$&:�� 0�� 0�

��4�� &'';A��'�"!.!�!�.�� 0 ��%&!&&:$:��0�� *#��4�� 2"��&'&'��-&�"!.!�!��3/&�!��

��%&!&(&$-'��0�� 0

��%&!&-3$:-��0��0�

��%&!&-3$:-!��&��=�

��1��&'''�!�� B� ��C� ��B� ��!C�

)*+,-./+,�00�1�2/-�3435�67�)8�9-,8:-;<,=�;.�>3754>1<61?61;;6@�8A<8+;+A+,�+B,�CD**DE;.F�9/-/F-/9B8�1=61>6�/.=�1,61>6�CD-�9/-/F-/9B8�1=61>6�/.=�1,61>6�DC�+B,�</8;:�:*/A8,�/8�CD**DE8G��1=61>6�HB,�IDJ9+-D**,-�K,.,-/*�DC�+B,�L.;+,=�M+/+,8@�/.�/99-D9-;/+,�0.89,:+D-�K,.,-/*�/99D;.+,=�A.=,-�8,:+;D.�5�D-�N�K�DC�+B,�0.89,:+D-�K,.,-/*�):+�DC�>OPN�1Q�L7M7I7�)9976@�D-�/.�/A+BD-;R,=�-,9-,8,.+/+;S,�DC�,;+B,-�DC�+B,�CD-,FD;.F�DCC;:;/*8�8B/**�B/S,�/::,88�+D�/.=�-;FB+�+DT��1;6�UV/J;.,�/.W�DC�+B,�ID.+-/:+D-X8�D-�/.W�8A<:D.+-/:+D-8X�-,:D-=8�+B/+�9,-+/;.�+D@�/.=�;.SD*S,�+-/.8/:+;D.8�-,*/+;.F�+D@�+B;8�:D.+-/:+Y�/.=��1;;6�0.+,-S;,E�/.W�DCC;:,-�D-�,J9*DW,,�-,F/-=;.F�8A:B�+-/.8/:+;D.87��1,61>6�ZD+E;+B8+/.=;.F�+B,�-,[A;-,J,.+8�DC�+B,�:*/A8,8�;.�9/-/F-/9B8�1/6@�1<6@�/.=�1:6@�DC�+B;8�:*/A8,@�+B,�ID.+-/:+D-�;8�.D+�-,[A;-,=�+D�C*DE�=DE.�/.W�\)]�:*/A8,�;.�/�8A<:D.+-/:+�CD-�:DJJ,-:;/*�9-D=A:+8�D-�:DJJ,-:;/*�8,-S;:,8@�D+B,-�+B/.T��1;6�̂/-/F-/9B�1=6�DC�+B;8�:*/A8,7�HB;8�9/-/F-/9B�C*DE8�=DE.�+D�/**�8A<:D.+-/:+8@�,V:,9+�+B,�/A+BD-;+W�DC�+B,�0.89,:+D-�K,.,-/*�A.=,-�9/-/F-/9B�1=61>61;;6�=D,8�.D+�C*DE�=DE.Y�/.=��1;;6�HBD8,�:*/A8,8�*;8+,=�;.�+B;8�9/-/F-/9B�1,61>67�L.*,88�D+B,-E;8,�;.=;:/+,=�<,*DE@�+B,�,V+,.+�DC�+B,�C*DE�=DE.�8B/**�<,�/8�-,[A;-,=�<W�+B,�:*/A8,_��1)6�Q37345_>5@�ID.+-/:+D-�ID=,�DC�̀A8;.,88�U+B;:8�/.=�ID.=A:+�1Zab�343>6�1?>�L7M7I7�5Q4O67��1̀6�Q37345_>Q@�cB;8+*,<*DE,-�̂-D+,:+;D.8�L.=,-�+B,�)J,-;:/.�],:DS,-W�/.=�],;.S,8+J,.+�):+�DC�344O�1dLZ�34>46�1M,:+;D.�>QQ5�DC�̂A<7�e7�>>>_Q67��1I6�Q3734?_35@�̂-DB;<;+;D.�D.�ID.+-/:+;.F�CD-�f/-=E/-,@�MDC+E/-,@�/.=�M,-S;:,8�g,S,*D9,=�D-�̂-DS;=,=�<W�h/89,-8iW�e/<�/.=�a+B,-�IDS,-,=�U.+;+;,8�1Zab�343>6�1M,:+;D.�>j5?�DC�̂A<7�e7�>>Q_O>67��1g6�Q3734?_3Q@�̂-DB;<;+;D.�D.�ID.+-/:+;.F�CD-�I,-+/;.�H,*,:DJJA.;:/+;D.8�/.=�b;=,D�MA-S,;**/.:,�M,-S;:,8�D-�U[A;9J,.+7�1Zab�343>6�1M,:+;D.�NNO1/61>61)6�DC�̂A<7�e7�>>Q_35367��1U6�Q373>O_N@�L+;*;R/+;D.�DC�MJ/**�̀A8;.,88�ID.:,-.8�1aIH�34336�1>Q�L7M7I7�j5P1=6136�/.=�1566@�;.�/**�8A<:D.+-/:+8�+B/+�DCC,-�CA-+B,-�8A<:D.+-/:+;.F�D99D-+A.;+;,87�0C�+B,�8A<:D.+-/:+�1,V:,9+�8A<:D.+-/:+8�+D�8J/**�<A8;.,88�:D.:,-.86�,V:,,=8�+B,�/99*;:/<*,�+B-,8BD*=�89,:;C;,=�;.�\)]�>O7P431/6�D.�+B,�=/+,�DC�8A<:D.+-/:+�/E/-=@�+B,�8A<:D.+-/:+D-�JA8+�;.:*A=,�Q373>O_N�;.�*DE,-�+;,-�8A<:D.+-/:+8�+B/+�DCC,-�8A<:D.+-/:+;.F�D99D-+A.;+;,87��1\6�Q37333_3>@�̂-DB;<;+;D.�DC�M,F-,F/+,=�\/:;*;+;,8�1)̂ ]�34>Q67��1K6�Q37333_3j@�U[A/*�a99D-+A.;+W�1MÛ�34>j6�1U7a7�>>3?j67��1f6�Q37333_5Q@�U[A/*�a99D-+A.;+W�CD-�b,+,-/.8�1dLZ�34346�15N�L7M7I7�?3>367��106�Q37333_5j@�U[A/*�a99D-+A.;+W�CD-�cD-i,-8�E;+B�g;8/<;*;+;,8�1dLZ�34346�13O�L7M7I7�PO567��1d6�Q37333_?4@�ZD+;C;:/+;D.�DC�UJ9*DW,,�];FB+8�L.=,-�+B,�Z/+;D./*�e/<D-�],*/+;D.8�):+�1gUI�34>46�1U7a7�>5?Oj67�\*DE�=DE.�-,[A;-,=�;.�/::D-=/.:,�E;+B�9/-/F-/9B�1C6�DC�\)]�:*/A8,�Q37333_?47��1h6�Q37333_?>@�M,-S;:,�ID.+-/:+�e/<D-�M+/.=/-=8�1)LK�34>N6�1?>�L7M7I7�:B/9+,-�jP67��1e6�kkk�1>6�Q37333_Q4@�IDJ</+;.F�H-/CC;:i;.F�;.�̂,-8D.8�1Zab�343>6�133�L7M7I7�:B/9+,-�PN�/.=�U7a�>5j3P67��kkk�136�)*+,-./+,�0�12)]�34>Q6�DC�Q37333_Q4�133�L7M7I7�:B/9+,-�PN�/.=�U7a7�>5j3P67��126�Q37333_Q>@�UV,J9+;D.�C-DJ�)99*;:/+;D.�DC�+B,�M,-S;:,�ID.+-/:+�e/<D-�M+/.=/-=8�+D�ID.+-/:+8�CD-�2/;.+,./.:,@�I/*;<-/+;D.@�D-�],9/;-�DC�I,-+/;.�U[A;9J,.+_],[A;-,J,.+8�12/W�34>?6�1?>�L7M7I7�:B/9+,-�jP67��1Z6�Q37333_Q5@�UV,J9+;D.�C-DJ�)99*;:/+;D.�DC�+B,�M,-S;:,�ID.+-/:+�e/<D-�M+/.=/-=8�+D�ID.+-/:+8�CD-�I,-+/;.�M,-S;:,8_],[A;-,J,.+8�12)l�34>?6�1?>�L7M7I7�:B/9+,-�jP67��1a6�Q37333_Q?@�UJ9*DWJ,.+�U*;F;<;*;+W�b,-;C;:/+;D.�1Zab�343>6�1UV,:A+;S,�a-=,-�>3ONO67��1̂6�Q37333_QQ@�2;.;JAJ�c/F,8�L.=,-�UV,:A+;S,�a-=,-�>5jQN�1d)Z�343367��1m6�Q37333_j3@�̂/;=�M;:i�e,/S,�L.=,-�UV,:A+;S,�a-=,-�>5P4j�1d)Z�34>P6�1U7a7�>5P4j67��1]6�1>6�Q3733?_5@�̂-;S/:W�H-/;.;.F�1d)Z�34>P6�1Q�L7M7I7�QQ3/67��136�)*+,-./+,�0�1d)Z�34>P6�DC�Q3733?_57��1M6�Q3733Q_3j@�ID.+-/:+D-8�̂,-CD-J;.F�̂-;S/+,�M,:A-;+W�\A.:+;D.8�aA+8;=,�+B,�L.;+,=�M+/+,8�1a:+�34>j6�1M,:+;D.�Nj3@�/8�/J,.=,=@�DC�+B,�Z/+;D./*�g,C,.8,�)A+BD-;R/+;D.�):+�CD-�\;8:/*�l,/-�344NY�>4�L7M7I7�MA<+;+*,�)@�̂/-+�b@�MA<9/-+�K�ZD+,67��1H6�Q3733j_j@�̂-DJD+;.F�UV:,88�\DD=�gD./+;D.�+D�ZD.9-DC;+�a-F/.;R/+;D.87�1dLZ�34346�1?3�L7M7I7�>PO367�\*DE�=DE.�-,[A;-,=�;.�/::D-=/.:,�E;+B�9/-/F-/9B�1,6�DC�\)]�:*/A8,�Q3733j_j7��1L6��Q37353_?4@�̂-DS;=;.F�)::,*,-/+,=�̂/WJ,.+8�+D�MJ/**�̀A8;.,88�MA<:D.+-/:+D-8�12)]�34356�1�5>�L7M7I7�5O45�/.=�>4�L7M7I7�5N4>67�\*DE�=DE.�-,[A;-,=�;.�/::D-=/.:,�E;+B�9/-/F-/9B�1:6�DC�Q37353_?47��1b6�Q373?P_j?@�̂-,C,-,.:,�CD-�̂-;S/+,*W�aE.,=�L7M7_\*/F�IDJJ,-:;/*�b,88,*8�1ZDS�343>6�1�?j�L7M7I7�QQ54Q�/.=�>4�L7M7I7�3j5>67�\*DE�=DE.�-,[A;-,=�;.�/::D-=/.:,�E;+B�9/-/F-/9B�1=6�DC�\)]�:*/A8,�Q373?P_j?7

Revised: March 7, 2022

Invoice and Payment Provisions The following clause is applicable to all Purchase Orders, Task or Delivery Orders, and Blanket Purchase

Agreement (BPA) Orders/Calls: Prompt Payment (Jan 2017) FAR 52.232-25. Highlights of this clause and

NIH implementation requirements follow:

I. Invoice Requirements A. An invoice is the Contractor's bill or written request for payment under the contract for supplies delivered or services performed. A proper invoice is an "Original" which must include the items listed in subdivisions 1 through 12, below, in addition to the requirements of FAR 32.9. If the invoice does not comply with these requirements, the Contractor will be notified of the defect within 7 days after the date the designated billing office received the invoice (3 days for meat, meat food products, or fish, and 5 days for perishable agricultural commodities, dairy products, edible fats or oils) with a statement of the reasons why it is not a proper invoice. (See exceptions under II., below.) Untimely notification will be taken into account in the computation of any interest penalty owed the Contractor.

1. Contractor: Name, Address, Point of Contact for the invoice (Name, title, telephone number, e-mail and mailing address of point of contact).

2. Remit-to address (Name and complete mailing address to send payment).

3. Remittance name must match exactly with name on original order/contract. If the Remittance name differs from the Legal Business Name, then both names must appear on the invoice.

4. Invoice date.

5. Unique invoice #s for all invoices per contractor regardless of site.

6. NBS document number formats must be included for awards created in the NBS: Contract Number;

Purchase Order Number; Task or Delivery Order Number and Source Award Number (e.g., Indefinite Delivery Contract number; General Services Administration number); or, BPA Call Number and BPA Parent Award Number.

7. Data Universal Numbering System (DUNS) or DUNS + 4 as registered in the Central Contractor Registration (CCR).

8. Federal Taxpayer Identification Number (TIN). In those exceptional cases where a contractor does not have a DUNS number or TIN, a Vendor Identification Number (VIN) must be referenced on the invoice. The VIN is the number that appears after the contractor’s name on the face page of the award document.

9. Identify that payment is to be made using a three-way match.

10. Description of supplies/services that match the description on the award, by line billed.*

11. Freight or delivery charge must be billed as shown on the award. If it is included in the item price do not bill it separately. If identified in the award as a separate line item, it must be billed separately.

12. Quantity, Unit of Measure, Unit Price, Extended Price of supplies delivered or services performed, as applicable, and that match the line items specified in the award.*

* NOTE: If your invoice must differ from the line items on the award, please contact the Contracting Officer before submitting the invoice. A modification to the order or contract may be needed before the invoice can be submitted and paid.

Invoice Processing Platform (IPP) Instructions

B. Shipping costs will be reimbursed only if authorized by the Contract/Purchase Order. If authorized, shipping costs must be itemized. Where shipping costs exceed $100, the invoice must be supported by a bill of lading or a paid carrier's receipt.

C. For inquiries regarding the status of invoices such as receipt of invoices, due date, request for payment of invoices, etc., contact NIH/OFM Customer Service via email at ofm_customer_service@incontactemail.com or via phone at 301-496-6088. To send your inquiries via other available communication methods see the NIH/OFM Customer Service website at https://ofm.od.nih.gov/Pages/Customer-Service.aspx.

The NIH/OFM Customer Service is open Eastern Standard Time Monday – Friday from 8:30 a.m. to 5:00 p.m. and is closed between 12:00 p.m. to 1:00 p.m.

In order to facilitate the prompt payment of invoices, it is recommended…

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated Aug 18, 2023.